Seeking Alpha

Affymax (AFFY -0.3%) CEO John Orwin says the days of biotech companies seeing their share price...

Affymax (AFFY -0.3%) CEO John Orwin says the days of biotech companies seeing their share price bid up on potential is over, as investors wait it out to see if firms hash out issues with reimbursements, regulatory hurdles, and safety concerns. "There was a time when products got full value prior to launch. I think we have now swung back in the other direction."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)